CD86 gene variants and susceptibility to pancreatic cancer
Honggang Xiang(Second Military Medical University), Zhiqian Hu(Tongji University), Houshan Yao(Second Military Medical University), Jian Xu(University of California, Los Angeles), Wei Zhao(University of Central Florida), Junjie Xing(South China Agricultural University), Yi Wang(Second Military Medical University), Yujia Zhou(Western University), Yanping Sun(Heilongjiang University of Chinese Medicine), Jun Yao(Nanjing Medical University), Winnie Qian(University of Toronto)
Cited by 16
Related Papers
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
|Gastric Cancer|2014|615
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
|Molecular Carcinogenesis|2010|558
Drug resistance to targeted therapeutic strategies in non-small cell lung cancer
|Pharmacology & Therapeutics|2019|245
Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations
|Nature Genetics|2011|198
Nanoparticle Systems for Cancer Vaccine
|Nanomedicine|2019|145